Literature DB >> 15472999

Determination of arginine and asymmetric dimethylarginine (ADMA) in human plasma by liquid chromatography/mass spectrometry with the isotope dilution technique.

Jens Martens-Lobenhoffer1, Olga Krug, Stefanie M Bode-Böger.   

Abstract

Arginine (ARG) is a substrate for endogenous nitric oxide (NO) production whereas its metabolite, asymmetric dimethylarginine (ADMA), acts as an inhibitor. Sufficient NO production is essential for cardiovascular key functions, thus elevated concentration levels of ADMA are related to a range of cardiovascular diseases. Owing to the lack of reliable methods for the measurement of ARG and ADMA in human plasma, concentration values determined with these methods can differ considerably. We present here a simple and very robust liquid chromatographic/mass spectrometric method for the determination of ARG and ADMA utilizing isotope-labeled internal standards. Sample preparation requires only protein precipitation; the analytes were derivatized with o-phthalaldehyde-mercaptoethanol and separated on a reversed-phase C(18) column with gradient elution. The analytes were detected with an electrospray ionization ion trap instrument working in the full-scan single mass spectrometry mode. Concentration values obtained with this method for healthy controls were ARG = 63.9 +/- 23.9 microM and ADMA = 0.355 +/- 0.066 microM, with a normal range for ADMA from 0.225 to 0.485 microM. The corresponding values for end-stage chronic renal failure patients are ARG = 48.1 +/- 18.5 microM, p < 0.01 and ADMA = 0.673 +/- 0.134 M, p < 0.001. Copyright (c) 2004 John Wiley & Sons, Ltd

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15472999     DOI: 10.1002/jms.684

Source DB:  PubMed          Journal:  J Mass Spectrom        ISSN: 1076-5174            Impact factor:   1.982


  8 in total

1.  Plasma levels of asymmetric dimethylarginine in patients with biopsy-proven nonalcoholic fatty liver disease.

Authors:  Takhar Kasumov; John M Edmison; Srinivasan Dasarathy; Carole Bennett; Rocio Lopez; Satish C Kalhan
Journal:  Metabolism       Date:  2010-09-23       Impact factor: 8.694

2.  Simultaneous bioanalysis of L-arginine, L-citrulline, and dimethylarginines by LC-MS/MS.

Authors:  Soyoung Shin; Sun-Mi Fung; Srinidi Mohan; Ho-Leung Fung
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2011-01-14       Impact factor: 3.205

3.  Hypothermia decreases cerebrospinal fluid asymmetric dimethylarginine levels in children with traumatic brain injury.

Authors:  Bhavani P Thampatty; Megan M Klamerus; Patrick J Oberly; Kerri L Feldman; Michael J Bell; Elizabeth C Tyler-Kabara; P David Adelson; Robert S B Clark; Patrick M Kochanek; Samuel M Poloyac
Journal:  Pediatr Crit Care Med       Date:  2013-05       Impact factor: 3.624

4.  Coordinated regulation of dimethylarginine dimethylaminohydrolase-1 and cationic amino acid transporter-1 by farnesoid X receptor in mouse liver and kidney and its implication in the control of blood levels of asymmetric dimethylarginine.

Authors:  Jiang Li; Annette Wilson; Xiang Gao; Ramalinga Kuruba; Youhua Liu; Samuel Poloyac; Bruce Pitt; Wen Xie; Song Li
Journal:  J Pharmacol Exp Ther       Date:  2009-07-15       Impact factor: 4.030

Review 5.  Asymmetrical dimethylarginine in renal disease: limits of variation or variation limits? A systematic review.

Authors:  Johannes Jacobi; Philip S Tsao
Journal:  Am J Nephrol       Date:  2007-10-24       Impact factor: 3.754

Review 6.  Toxic Dimethylarginines: Asymmetric  Dimethylarginine (ADMA) and Symmetric  Dimethylarginine (SDMA).

Authors:  You-Lin Tain; Chien-Ning Hsu
Journal:  Toxins (Basel)       Date:  2017-03-06       Impact factor: 4.546

Review 7.  Asymmetric dimethylarginine, endothelial dysfunction and renal disease.

Authors:  Luis Aldámiz-Echevarría; Fernando Andrade
Journal:  Int J Mol Sci       Date:  2012-09-10       Impact factor: 6.208

8.  Determination of Asymmetric and Symmetric Dimethylarginine in Serum from Patients with Chronic Kidney Disease: UPLC-MS/MS versus ELISA.

Authors:  Jente Boelaert; Eva Schepers; Griet Glorieux; Sunny Eloot; Raymond Vanholder; Frédéric Lynen
Journal:  Toxins (Basel)       Date:  2016-05-13       Impact factor: 4.546

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.